A nurse is providing care for a client with hypokalemia. Which condition should the nurse monitor for?

Choice A Reason:

Conivaptan hydrochloride is a vasopressin receptor antagonist used to treat hyponatremia associated with SIADH. It works by blocking the action of ADH, thereby promoting water excretion without losing sodium. This medication is appropriate for managing SIADH.

Choice B Reason:

Vasopressin, also known as antidiuretic hormone (ADH), is not appropriate for a patient with SIADH. SIADH is characterized by excessive release of ADH, leading to water retention and hyponatremia. Administering vasopressin would exacerbate the condition by increasing water retention and further lowering sodium levels.

Choice C Reason:

Sodium chloride tablets are used to manage hyponatremia by increasing sodium levels in the blood. This treatment is appropriate for patients with SIADH to help correct the sodium imbalance caused by excessive ADH.

Choice D Reason:

Tolvaptan is another vasopressin receptor antagonist that is used to treat hyponatremia associated with SIADH. It helps to increase serum sodium levels by promoting water excretion while retaining sodium. This medication is suitable for managing SIADH.

Choice A Reason:

Dietary and fluid restrictions are crucial for managing heart failure. Patients with heart failure often experience fluid retention, which can exacerbate symptoms such as swelling, shortness of breath, and fatigue. By restricting fluid intake, patients can help prevent fluid overload. Additionally, dietary modifications, such as reducing sodium intake, can help manage blood pressure and reduce the risk of fluid retention. Sodium causes the body to retain water, which can increase the workload on the heart. Therefore, a low-sodium diet is often recommended for heart failure patients. These restrictions are essential to prevent the worsening of heart failure symptoms and to improve the patient’s quality of life.

Choice B Reason:

Encouraging increased mobility is generally beneficial for overall health, but it must be approached cautiously in heart failure patients. While regular physical activity can help improve cardiovascular health and overall well-being, it is important to tailor the exercise regimen to the patient’s condition. Overexertion can lead to worsening symptoms or complications. Therefore, while increased mobility can be part of the management plan, it should be done under medical supervision and is not the primary lifestyle modification for heart failure management.

Choice C Reason:

Cessation of hormonal supplements may be relevant for some patients, particularly if the supplements are contributing to fluid retention or other adverse effects. However, this is not a standard recommendation for all heart failure patients. The decision to stop hormonal supplements would depend on the individual patient’s medical history and the specific supplements they are taking. It is not a general lifestyle modification for heart failure management.

Choice D Reason:

Cessation of intravenous (IV) drug use is important for patients who may be using IV drugs, as this can lead to infections, endocarditis, and other complications that can worsen heart failure. However, this recommendation is specific to patients with a history of IV drug use and is not a general lifestyle modification for all heart failure patients. The primary focus for most heart failure patients would be on managing fluid and dietary intake.